Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Real-Time Studies Show How an Effector Protein Regulates Cellular Gene Expression

By LabMedica International staff writers
Posted on 29 Jun 2015
A series of elegant single molecule experiments have revealed in real-time how the effector protein HP1alpha interacts with chromatin in its target histones to regulate gene expression.

Cells regulate gene activity at any given time by unwinding specific areas of the packed chromatin (histone-DNA) complex. More...
Conversely, the cell can silence genes by forming compact and dense chromatin fibers that prevent gene expression. This remodeling is carried out by "effector" proteins, which attach to chromatin and change the three-dimensional structure of the gene of interest to either an open or compact format.

The effector protein HP1alpha is an isoform of the heterochromatin protein 1 (HP1), which plays a role in chromatin remodeling and transcriptional silencing. The HP1 chromo domain selectively recognizes the methylated histones H3-K9, where this methylation is carried out by histone methyltransferase SUV39H1.

Investigators at the Ecole Polytechnique Fédérale de Lausanne (Switzerland) established a fully chemically defined assay system to directly observe the real-time interaction dynamics of individual HP1alpha molecules with their target posttranslational modification (PTMs) histone sites within their native context, nucleosome arrays. This approach was highly complementary to measurements of chromatin effector dynamics in cells, as the investigators maintained complete control over the chromatin architecture and modification status.

Employing chemically defined nucleosome arrays together with single-molecule total internal reflection fluorescence microscopy (smTIRFM), the investigators demonstrated in a paper published in the June 18, 2015, online edition of the journal Nature Communications that HP1alpha residence time on chromatin depended on the density of H3K9me3 histone, as dissociated factors could rapidly rebind at neighboring sites. Moreover, by chemically controlling HP1alpha dimerization they found that effector multivalency prolonged chromatin retention and, importantly, accelerated the association rate.

Senior author Dr. Beat Fierz, professor of biophysical chemistry of macromolecules at Ecole Polytechnique Fédérale de Lausanne, said, "We want to observe complex biology as it happens, and understand it on a quantitative level. Our chemical methods give us complete control over protein-chromatin dynamics, and the current study sets the stage for such unprecedented insights."

Related Links:

Ecole Polytechnique Fédérale de Lausanne



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.